Log in to save to my catalogue

Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Formi...

Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Formi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_22286058

Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type

About this item

Full title

Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Pathobiology (Basel), 2012-01, Vol.79 (2), p.101-106

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Objectives: MUC16 carries the peptide epitope CA125, which is well known as a marker of ovarian cancer. High serum levels of MUC16 (CA125) have been reported not only in patients with ovarian cancer but also in patients with liver diseases. We evaluated the expression of MUC16 in intrahepatic cholangiocarcinoma-mass forming type (ICC-MF) tissues. M...

Alternative Titles

Full title

Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_22286058

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_22286058

Other Identifiers

ISSN

1015-2008

E-ISSN

1423-0291

DOI

10.1159/000335164

How to access this item